<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35584812</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1750-3639</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Brain pathology (Zurich, Switzerland)</Title><ISOAbbreviation>Brain Pathol</ISOAbbreviation></Journal><ArticleTitle>Accumulation of misfolded SOD1 outlines distinct patterns of motor neuron pathology and death during disease progression in a SOD1<sup>G93A</sup> mouse model of amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>e13078</StartPage><MedlinePgn>e13078</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e13078</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1111/bpa.13078</ELocationID><Abstract><AbstractText>Early misfolded superoxide dismutase 1 (mfSOD1) accumulation, motor neuron (MN) degeneration, and microgliosis are hallmark pathological features in SOD1<sup>G93A</sup> amyotrophic lateral sclerosis (ALS) mice. Because of the different vulnerabilities of distinct MN subtypes, degenerating and surviving MNs coexist in different proportions during disease progression. By examining the expression of misfolded conformers of SOD1 using specific antibodies, we defined distinct MN phenotypes that were evaluated during disease progression and the local neuroinflammatory reaction. The most severe phenotype corresponded to somata of fast-twitch subtype MNs, which exhibited highly positive mfSOD1 immunostaining and an extreme degree of vacuolar degeneration. Vacuoles, which are of mitochondrial origin, contain mfSOD1 in conjunction with nonmitochondrial proteins, such as chromogranin, CD81, and flotillin. The fusion of ER-derived vesicles enriched in mfSOD1 with outer mitochondrial membranes is thought to be the primary mechanism for vacuole formation. In addition, the ulterior coalescence of enlarged mitochondria may lead to the formation of giant vacuoles. Vacuolar degeneration is a transient degenerative process occurring early during the presymptomatic stages of the disease in ALS mice. Some vacuolated MNs are also positive for pMLKL, the effector protein of necroptosis. This indicates a newly described mechanism in which extracellular vesicles derived from damaged MNs, via cellular secretion or necroptotic disruption, may be the triggers for initiating neuroinflammation, glial-mediated neurotoxicity, and disease spreading. Furthermore, as MN degeneration in mutant SOD1 mice is noncell autonomous, the effects of experimentally increasing or decreasing the microglial response on the expression of MN phenotypes were also evaluated, demonstrating bidirectional cross talk signaling between the degree of expression of mfSOD1 and local neuroinflammation. More detailed knowledge regarding these processes occurring long before the end stages of the disease is necessary to identify novel molecular targets for future preclinical testing.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Brain Pathology published by John Wiley &amp; Sons Ltd on behalf of International Society of Neuropathology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Salvany</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Patologia Neuromuscular Experimental, Departament de Medicina Experimental, Facultat de Medicina, Universitat de Lleida and Institut de Recerca Biom&#xe8;dica de Lleida (IRBLleida), Lleida, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casanovas</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Patologia Neuromuscular Experimental, Departament de Medicina Experimental, Facultat de Medicina, Universitat de Lleida and Institut de Recerca Biom&#xe8;dica de Lleida (IRBLleida), Lleida, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piedrafita</LastName><ForeName>L&#xed;dia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Patologia Neuromuscular Experimental, Departament de Medicina Experimental, Facultat de Medicina, Universitat de Lleida and Institut de Recerca Biom&#xe8;dica de Lleida (IRBLleida), Lleida, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gras</LastName><ForeName>S&#xed;lvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Patologia Neuromuscular Experimental, Departament de Medicina Experimental, Facultat de Medicina, Universitat de Lleida and Institut de Recerca Biom&#xe8;dica de Lleida (IRBLleida), Lleida, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calder&#xf3;</LastName><ForeName>Jordi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Patologia Neuromuscular Experimental, Departament de Medicina Experimental, Facultat de Medicina, Universitat de Lleida and Institut de Recerca Biom&#xe8;dica de Lleida (IRBLleida), Lleida, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esquerda</LastName><ForeName>Josep E</ForeName><Initials>JE</Initials><Identifier Source="ORCID">0000-0003-1413-2103</Identifier><AffiliationInfo><Affiliation>Patologia Neuromuscular Experimental, Departament de Medicina Experimental, Facultat de Medicina, Universitat de Lleida and Institut de Recerca Biom&#xe8;dica de Lleida (IRBLleida), Lleida, Catalonia, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Brain Pathol</MedlineTA><NlmUniqueID>9216781</NlmUniqueID><ISSNLinking>1015-6305</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="C000606291">Sod1 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="Y">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057165" MajorTopicYN="N">Proteostasis Deficiencies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SOD1</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">microglia</Keyword><Keyword MajorTopicYN="N">motor neuron</Keyword><Keyword MajorTopicYN="N">necroptosis</Keyword><Keyword MajorTopicYN="N">vacuolar degeneration</Keyword></KeywordList><CoiStatement>SS, AC, LP, SG, JC, and JE have no competing interests concerning this study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>18</Day><Hour>20</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35584812</ArticleId><ArticleId IdType="pmc">PMC9616096</ArticleId><ArticleId IdType="doi">10.1111/bpa.13078</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rowland LP. Hereditary and acquired motor neuron diseases. City: Williams &amp; Wilkins; 1995.</Citation></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. 10.1038/362059a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn LI, Miller TM, Cleveland DW. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci. 2004;27:723&#x2013;49. 10.1146/annurev.neuro.27.070203.144244</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.neuro.27.070203.144244</ArticleId><ArticleId IdType="pubmed">15217349</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendotti C, Carri MT. Lessons from models of SOD1&#x2010;linked familial ALS. Trends Mol Med. 2004;10:393&#x2013;400. 10.1016/j.molmed.2004.06.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2004.06.009</ArticleId><ArticleId IdType="pubmed">15310460</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L, Kirby J, Grierson AJ, Sendtner M, Shaw PJ. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat Rev Neurol. 2011;7:616&#x2013;30. 10.1038/nrneurol.2011.152</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.152</ArticleId><ArticleId IdType="pubmed">22051914</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;5. 10.1126/science.8209258</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato S. Amyotrophic lateral sclerosis models and human neuropathology: similarities and differences. Acta Neuropathol. 2008;115:97&#x2013;114. 10.1007/s00401-007-0308-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-007-0308-4</ArticleId><ArticleId IdType="pubmed">18026741</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner BJ, Talbot K. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1&#x2010;mediated familial ALS. Prog Neurobiol. 2008;85:94&#x2013;134. 10.1016/j.pneurobio.2008.01.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2008.01.001</ArticleId><ArticleId IdType="pubmed">18282652</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu AY, Zhai P, Dal Canto MC, Peters TM, Kwon YW, Prattis SM, et al. Age&#x2010;dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol Cell Neurosci. 1995;6:349&#x2013;62. 10.1006/mcne.1995.1027</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/mcne.1995.1027</ArticleId><ArticleId IdType="pubmed">8846004</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall ED, Oostveen JA, Gurney ME. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia. 1998;23:249&#x2013;56. 10.1002/(sici)1098-1136(199807)23:3&lt;249::aid-glia7&gt;3.0.co;2-0023</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(sici)1098-1136(199807)23:3&lt;249::aid-glia7&gt;3.0.co;2-0023</ArticleId><ArticleId IdType="pubmed">9633809</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegedus J, Putman CT, Gordon T. Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neurobiol Dis. 2007;28:154&#x2013;64. 10.1016/j.nbd.2007.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2007.07.003</ArticleId><ArticleId IdType="pubmed">17766128</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijssen J, Comley LH, Hedlund E. Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis. Acta Neuropathol. 2017;133:863&#x2013;85. 10.1007/s00401-017-1708-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1708-8</ArticleId><ArticleId IdType="pmc">PMC5427160</ArticleId><ArticleId IdType="pubmed">28409282</ArticleId></ArticleIdList></Reference><Reference><Citation>Pun S, Santos AF, Saxena S, Xu L, Caroni P. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat Neurosci. 2006;9:408&#x2013;19. 10.1038/nn1653</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1653</ArticleId><ArticleId IdType="pubmed">16474388</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanning KC, Kaplan A, Henderson CE. Motor neuron diversity in development and disease. Annu Rev Neurosci. 2010;33:409&#x2013;40. 10.1146/annurev.neuro.051508.135722</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.neuro.051508.135722</ArticleId><ArticleId IdType="pubmed">20367447</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena S, Roselli F, Singh K, Leptien K, Julien JP, Gros&#x2010;Louis F, et al. Neuroprotection through excitability and mTOR required in ALS motoneurons to delay disease and extend survival. Neuron. 2013;80:80&#x2013;96. 10.1016/j.neuron.2013.07.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.027</ArticleId><ArticleId IdType="pubmed">24094105</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalancette&#x2010;Hebert M, Sharma A, Lyashchenko AK, Shneider NA. Gamma motor neurons survive and exacerbate alpha motor neuron degeneration in ALS. Proc Natl Acad Sci USA. 2016;113:E8316&#x2013;25. 10.1073/pnas.1605210113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1605210113</ArticleId><ArticleId IdType="pmc">PMC5187676</ArticleId><ArticleId IdType="pubmed">27930290</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaefer AM, Sanes JR, Lichtman JW. A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis. J Comp Neurol. 2005;490:209&#x2013;19. 10.1002/cne.20620</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.20620</ArticleId><ArticleId IdType="pubmed">16082680</ArticleId></ArticleIdList></Reference><Reference><Citation>Boillee S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 2006;312:1389&#x2013;92. 10.1126/science.1123511</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1123511</ArticleId><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Clement AM, Nguyen MD, Roberts EA, Garcia ML, Boillee S, Rule M, et al. Wild&#x2010;type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science. 2003;302:113&#x2013;7. 10.1126/science.1086071</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1086071</ArticleId><ArticleId IdType="pubmed">14526083</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva H, Polymenidou M, Cleveland DW. Non&#x2010;cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol. 2009;187:761&#x2013;72. 10.1083/jcb.200908164</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200908164</ArticleId><ArticleId IdType="pmc">PMC2806318</ArticleId><ArticleId IdType="pubmed">19951898</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer LR, Culver DG, Tennant P, Davis AA, Wang MS, Castellano&#x2010;Sanchez A, et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol. 2004;185:232&#x2013;40. 10.1016/j.expneurol.2003.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2003.10.004</ArticleId><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldskogius H. Mechanisms and consequences of microglial responses to peripheral axotomy. Front Biosci. 2011;3:857&#x2013;68. 10.2741/192</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/192</ArticleId><ArticleId IdType="pubmed">21622237</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotterman TM, Alvarez FJ. Microglia dynamics and interactions with motoneurons axotomized after nerve injuries revealed by two&#x2010;photon imaging. Sci Rep. 2020;10:8648. 10.1038/s41598-020-65363-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-65363-9</ArticleId><ArticleId IdType="pmc">PMC7250868</ArticleId><ArticleId IdType="pubmed">32457369</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvany S, Casanovas A, Piedrafita L, Tarabal O, Hern&#xe1;ndez S, Calder&#xf3; J, et al. Microglial recruitment and mechanisms involved in the disruption of afferent synaptic terminals on spinal cord motor neurons after acute peripheral nerve injury. Glia. 2021;69:1216&#x2013;40. 10.1002/glia.23959</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23959</ArticleId><ArticleId IdType="pmc">PMC7986680</ArticleId><ArticleId IdType="pubmed">33386754</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowrie MB, Vrbov&#xe1; G. Dependence of postnatal motoneurones on their targets: review and hypothesis. Trends Neurosci. 1992;15:80&#x2013;4. 10.1016/0166-2236(92)90014-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0166-2236(92)90014-y</ArticleId><ArticleId IdType="pubmed">1373920</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollin MM, McHanwell S, Slater CR. The effect of age on motor neurone death following axotomy in the mouse. Development. 1991;112:83&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">1769343</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotterman TM, Akhter ET, Lane AR, MacPherson KP, Garcia VV, Tansey MG, et al. Spinal motor circuit synaptic plasticity after peripheral nerve injury depends on microglia activation and a CCR2 mechanism. J Neurosci. 2019;39:3412&#x2013;33. 10.1523/JNEUROSCI.2945-17.2019</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2945-17.2019</ArticleId><ArticleId IdType="pmc">PMC6495126</ArticleId><ArticleId IdType="pubmed">30833511</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira AL, Thams S, Lidman O, Piehl F, Hokfelt T, Karre K, et al. A role for MHC class I molecules in synaptic plasticity and regeneration of neurons after axotomy. Proc Natl Acad Sci USA. 2004;101:17843&#x2013;8. 10.1073/pnas.0408154101</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0408154101</ArticleId><ArticleId IdType="pmc">PMC539738</ArticleId><ArticleId IdType="pubmed">15591351</ArticleId></ArticleIdList></Reference><Reference><Citation>Svensson M, Aldskogius H. Synaptic density of axotomized hypoglossal motorneurons following pharmacological blockade of the microglial cell proliferation. Exp Neurol. 1993;120:123&#x2013;31. 10.1006/exnr.1993.1046</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/exnr.1993.1046</ArticleId><ArticleId IdType="pubmed">8477825</ArticleId></ArticleIdList></Reference><Reference><Citation>Ripps ME, Huntley GW, Hof PR, Morrison JH, Gordon JW. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA. 1995;92:689&#x2013;93. 10.1073/pnas.92.3.689</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.92.3.689</ArticleId><ArticleId IdType="pmc">PMC42685</ArticleId><ArticleId IdType="pubmed">7846037</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancuso R, Oliv&#xe1;n S, Mancera P, Past&#xe9;n&#x2010;Zamorano A, Manzano R, Casas C, Osta R, Navarro X. Effect of genetic background on onset and disease progression in the SOD1&#x2010;G93A model of amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2012;13:302&#x2013;10. 10.3109/17482968.2012.662688</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.662688</ArticleId><ArticleId IdType="pubmed">22424126</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;nther R, Suhr M, Koch JC, B&#xe4;hr M, Lingor P, T&#xf6;nges L. Clinical testing and spinal cord removal in a mouse model for amyotrophic lateral sclerosis (ALS). J Vis Exp. 2012;(61):3936. 10.3791/3936</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/3936</ArticleId><ArticleId IdType="pmc">PMC3415170</ArticleId><ArticleId IdType="pubmed">22453893</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkholder T, Foltz C, Karlsson E, Linton CG, Smith JM. Health Evaluation of Experimental Laboratory Mice. Curr Protoc Mouse Biol. 2012;2:145&#x2013;65. 10.1002/9780470942390.mo110217</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/9780470942390.mo110217</ArticleId><ArticleId IdType="pmc">PMC3399545</ArticleId><ArticleId IdType="pubmed">22822473</ArticleId></ArticleIdList></Reference><Reference><Citation>Elmore MR, Najafi AR, Koike MA, Dagher NN, Spangenberg EE, Rice RA, et al. Colony&#x2010;stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron. 2014;82:380&#x2013;97. 10.1016/j.neuron.2014.02.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.02.040</ArticleId><ArticleId IdType="pmc">PMC4161285</ArticleId><ArticleId IdType="pubmed">24742461</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke PGH, Oppenheim RW. Neuron death in vertebrate development &#x2010; in&#x2010;vivo methods. Methods Cell Biol. 1995;46:277&#x2013;321.</Citation><ArticleIdList><ArticleId IdType="pubmed">7609654</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson C, Paxinos G, Kayalioglu G, Heise C. The spinal cord. City: Elsevier; 2009.</Citation></Reference><Reference><Citation>Rubio ME, Wenthold RJ. Differential distribution of intracellular glutamate receptors in dendrites. J Neurosci. 1999;19:5549&#x2013;62. 10.1523/jneurosci.19-13-05549.1999</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/jneurosci.19-13-05549.1999</ArticleId><ArticleId IdType="pmc">PMC6782302</ArticleId><ArticleId IdType="pubmed">10377362</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco DA, Morfini G, Karabacak NM, Song Y, Gros&#x2010;Louis F, Pasinelli P, et al. Wild&#x2010;type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat Neurosci. 2010;13:1396&#x2013;403. 10.1038/nn.2660</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2660</ArticleId><ArticleId IdType="pmc">PMC2967729</ArticleId><ArticleId IdType="pubmed">20953194</ArticleId></ArticleIdList></Reference><Reference><Citation>Brotherton TE, Li Y, Cooper D, Gearing M, Julien JP, Rothstein JD, et al. Localization of a toxic form of superoxide dismutase 1 protein to pathologically affected tissues in familial ALS. Proc Natl Acad Sci USA. 2012;109:5505&#x2013;10. 10.1073/pnas.1115009109</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1115009109</ArticleId><ArticleId IdType="pmc">PMC3325721</ArticleId><ArticleId IdType="pubmed">22431618</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujisawa T, Homma K, Yamaguchi N, Kadowaki H, Tsuburaya N, Naguro I, et al. A novel monoclonal antibody reveals a conformational alteration shared by amyotrophic lateral sclerosis&#x2010;linked SOD1 mutants. Ann Neurol. 2012;72:739&#x2013;49. 10.1002/ana.23668</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23668</ArticleId><ArticleId IdType="pubmed">23280792</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez S, Casanovas A, Piedrafita L, Tarabal O, Esquerda JE. Neurotoxic species of misfolded SOD1G93A recognized by antibodies against the P2X4 subunit of the ATP receptor accumulate in damaged neurons of transgenic animal models of amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 2010;69:176&#x2013;87. 10.1097/NEN.0b013e3181cd3e33</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e3181cd3e33</ArticleId><ArticleId IdType="pubmed">20084016</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier M, Welt T, Wirth F, Montrasio F, Preisig D, McAfoose J, et al. A human&#x2010;derived antibody targets misfolded SOD1 and ameliorates motor symptoms in mouse models of amyotrophic lateral sclerosis. Sci Transl Med. 2018;10. 10.1126/scitranslmed.aah3924</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aah3924</ArticleId><ArticleId IdType="pubmed">30518612</ArticleId></ArticleIdList></Reference><Reference><Citation>Pare B, Lehmann M, Beaudin M, Nordstrom U, Saikali S, Julien JP, et al. Misfolded SOD1 pathology in sporadic amyotrophic lateral sclerosis. Sci Rep. 2018;8:14223. 10.1038/s41598-018-31773-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-31773-z</ArticleId><ArticleId IdType="pmc">PMC6155098</ArticleId><ArticleId IdType="pubmed">30242181</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickles S, Vande Velde C. Misfolded SOD1 and ALS: zeroing in on mitochondria. Amyotroph Lateral Scler. 2012;13:333&#x2013;40. 10.3109/17482968.2012.648645</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.648645</ArticleId><ArticleId IdType="pubmed">22471903</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakhit R, Robertson J, Vande Velde C, Horne P, Ruth DM, Griffin J, et al. An immunological epitope selective for pathological monomer&#x2010;misfolded SOD1 in ALS. Nat Med. 2007;13:754&#x2013;9. 10.1038/nm1559</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1559</ArticleId><ArticleId IdType="pubmed">17486090</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;bado J, Casanovas A, Hernandez S, Piedrafita L, Hereu M, Esquerda JE. Immunodetection of disease&#x2010;associated conformers of mutant Cu/Zn superoxide dismutase 1 selectively expressed in degenerating neurons in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 2013;72:646&#x2013;61. 10.1097/NEN.0b013e318297fd10</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e318297fd10</ArticleId><ArticleId IdType="pubmed">23771221</ArticleId></ArticleIdList></Reference><Reference><Citation>Urushitani M, Ezzi SA, Julien JP. Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA. 2007;104:2495&#x2013;500. 10.1073/pnas.0606201104</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0606201104</ArticleId><ArticleId IdType="pmc">PMC1790867</ArticleId><ArticleId IdType="pubmed">17277077</ArticleId></ArticleIdList></Reference><Reference><Citation>Redler RL, Fee L, Fay JM, Caplow M, Dokholyan NV. Non&#x2010;native soluble oligomers of Cu/Zn superoxide dismutase (SOD1) contain a conformational epitope linked to cytotoxicity in amyotrophic lateral sclerosis (ALS). Biochemistry. 2014;53:2423&#x2013;32. 10.1021/bi500158w</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi500158w</ArticleId><ArticleId IdType="pmc">PMC4004233</ArticleId><ArticleId IdType="pubmed">24660965</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsberg K, Jonsson PA, Andersen PM, Bergemalm D, Graffmo KS, Hultdin M, et al. Novel antibodies reveal inclusions containing non&#x2010;native SOD1 in sporadic ALS patients. PLoS One. 2010;5:e11552. 10.1371/journal.pone.0011552</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0011552</ArticleId><ArticleId IdType="pmc">PMC2904380</ArticleId><ArticleId IdType="pubmed">20644736</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotunno MS, Bosco DA. An emerging role for misfolded wild&#x2010;type SOD1 in sporadic ALS pathogenesis. Front Cell Neurosci. 2013;7:253. 10.3389/fncel.2013.00253</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00253</ArticleId><ArticleId IdType="pmc">PMC3863749</ArticleId><ArticleId IdType="pubmed">24379756</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Lillo C, Jonsson PA, Vande Velde C, Ward CM, Miller TM, et al. Toxicity of familial ALS&#x2010;linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron. 2004;43:5&#x2013;17. 10.1016/j.neuron.2004.06.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.06.016</ArticleId><ArticleId IdType="pubmed">15233913</ArticleId></ArticleIdList></Reference><Reference><Citation>Vande Velde C, Miller TM, Cashman NR, Cleveland DW. Selective association of misfolded ALS&#x2010;linked mutant SOD1 with the cytoplasmic face of mitochondria. Proc Natl Acad Sci USA. 2008;105:4022&#x2013;7. 10.1073/pnas.0712209105</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0712209105</ArticleId><ArticleId IdType="pmc">PMC2268797</ArticleId><ArticleId IdType="pubmed">18296640</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins CM, Jung C, Xu Z. ALS&#x2010;associated mutant SOD1G93A causes mitochondrial vacuolation by expansion of the intermembrane space and by involvement of SOD1 aggregation and peroxisomes. BMC Neurosci. 2003;4:16. 10.1186/1471-2202-4-16</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2202-4-16</ArticleId><ArticleId IdType="pmc">PMC169170</ArticleId><ArticleId IdType="pubmed">12864925</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaarsma D, Rognoni F, van Duijn W, Verspaget HW, Haasdijk ED, Holstege JC. CuZn superoxide dismutase (SOD1) accumulates in vacuolated mitochondria in transgenic mice expressing amyotrophic lateral sclerosis&#x2010;linked SOD1 mutations. Acta Neuropathol. 2001;102:293&#x2013;305. 10.1007/s004010100399</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004010100399</ArticleId><ArticleId IdType="pubmed">11603803</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, Jenkins NA, et al. An adverse property of a familial ALS&#x2010;linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron. 1995;14:1105&#x2013;16. 10.1016/0896-6273(95)90259-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(95)90259-7</ArticleId><ArticleId IdType="pubmed">7605627</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong J, Xu Z. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J Neurosci. 1998;18:3241&#x2013;50. 10.1523/JNEUROSCI.18-09-03241.1998</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.18-09-03241.1998</ArticleId><ArticleId IdType="pmc">PMC6792665</ArticleId><ArticleId IdType="pubmed">9547233</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinsant S, Mansfield C, Jimenez&#x2010;Moreno R, Del Gaizo MV, Yoshikawa M, Hampton TG, et al. Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: part I, background and methods. Brain Behav. 2013;3:335&#x2013;50. 10.1002/brb3.143</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.143</ArticleId><ArticleId IdType="pmc">PMC3869677</ArticleId><ArticleId IdType="pubmed">24381807</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinsant S, Mansfield C, Jimenez&#x2010;Moreno R, Del Gaizo MV, Yoshikawa M, Hampton TG, et al. Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: part II, results and discussion. Brain Behav. 2013;3:431&#x2013;57. 10.1002/brb3.142</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.142</ArticleId><ArticleId IdType="pmc">PMC3869683</ArticleId><ArticleId IdType="pubmed">24381813</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendotti C, Calvaresi N, Chiveri L, Prelle A, Moggio M, Braga M, et al. Early vacuolization and mitochondrial damage in motor neurons of FALS mice are not associated with apoptosis or with changes in cytochrome oxidase histochemical reactivity. J Neurol Sci. 2001;191:25&#x2013;33. 10.1016/S0022-510x(01)00627-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510x(01)00627-X</ArticleId><ArticleId IdType="pubmed">11676989</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin LJ, Liu Z, Chen K, Price AC, Pan Y, Swaby JA, et al. Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase&#x2010;1 transgenic mice: mechanisms of mitochondriopathy and cell death. J Comp Neurol. 2007;500:20&#x2013;46. 10.1002/cne.21160</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.21160</ArticleId><ArticleId IdType="pubmed">17099894</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim E, Lee DM, Seo MJ, Lee HJ, Choi KS. Intracellular Ca(2 +) imbalance critically contributes to paraptosis. Front Cell Dev Biol. 2020;8:607844. 10.3389/fcell.2020.607844</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.607844</ArticleId><ArticleId IdType="pmc">PMC7873879</ArticleId><ArticleId IdType="pubmed">33585447</ArticleId></ArticleIdList></Reference><Reference><Citation>Sperandio S, de Belle I, Bredesen DE. An alternative, nonapoptotic form of programmed cell death. Proc Natl Acad Sci USA. 2000;97:14376&#x2013;81. 10.1073/pnas.97.26.14376</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.97.26.14376</ArticleId><ArticleId IdType="pmc">PMC18926</ArticleId><ArticleId IdType="pubmed">11121041</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan A, Spiller KJ, Towne C, Kanning KC, Choe GT, Geber A, et al. Neuronal matrix metalloproteinase&#x2010;9 is a determinant of selective neurodegeneration. Neuron. 2014;81:333&#x2013;48. 10.1016/j.neuron.2013.12.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.12.009</ArticleId><ArticleId IdType="pmc">PMC6015650</ArticleId><ArticleId IdType="pubmed">24462097</ArticleId></ArticleIdList></Reference><Reference><Citation>Urushitani M, Sik A, Sakurai T, Nukina N, Takahashi R, Julien JP. Chromogranin&#x2010;mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat Neurosci. 2006;9:108&#x2013;18. 10.1038/nn1603</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1603</ArticleId><ArticleId IdType="pubmed">16369483</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowal J, Arras G, Colombo M, Jouve M, Morath JP, Primdal&#x2010;Bengtson B, et al. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci USA. 2016;113:E968&#x2013;77. 10.1073/pnas.1521230113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1521230113</ArticleId><ArticleId IdType="pmc">PMC4776515</ArticleId><ArticleId IdType="pubmed">26858453</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilcaes AA, Chanaday NL, Kavalali ET. Interneuronal exchange and functional integration of synaptobrevin via extracellular vesicles. Neuron. 2021;109:971&#x2013;983.e975. 10.1016/j.neuron.2021.01.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2021.01.007</ArticleId><ArticleId IdType="pmc">PMC7979516</ArticleId><ArticleId IdType="pubmed">33513363</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Sun L, Su L, Rizo J, Liu L, Wang LF, et al. Mixed lineage kinase domain&#x2010;like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol Cell. 2014;54:133&#x2013;46. 10.1016/j.molcel.2014.03.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2014.03.003</ArticleId><ArticleId IdType="pubmed">24703947</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Acunzo P, Perez&#x2010;Gonzalez R, Kim Y, Hargash T, Miller C, Alldred MJ, et al. Mitovesicles are a novel population of extracellular vesicles of mitochondrial origin altered in Down syndrome. Sci Adv. 2021;7. 10.1126/sciadv.abe5085</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abe5085</ArticleId><ArticleId IdType="pmc">PMC7880603</ArticleId><ArticleId IdType="pubmed">33579698</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudnick ND, Griffey CJ, Guarnieri P, Gerbino V, Wang X, Piersaint JA, et al. Distinct roles for motor neuron autophagy early and late in the SOD1(G93A) mouse model of ALS. Proc Natl Acad Sci USA. 2017;114:E8294&#x2013;303. 10.1073/pnas.1704294114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1704294114</ArticleId><ArticleId IdType="pmc">PMC5625902</ArticleId><ArticleId IdType="pubmed">28904095</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada T, Dawson TM, Yanagawa T, Iijima M, Sesaki H. SQSTM1/p62 promotes mitochondrial ubiquitination independently of PINK1 and PRKN/parkin in mitophagy. Autophagy. 2019;15:2012&#x2013;8. 10.1080/15548627.2019.1643185</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2019.1643185</ArticleId><ArticleId IdType="pmc">PMC6844492</ArticleId><ArticleId IdType="pubmed">31339428</ArticleId></ArticleIdList></Reference><Reference><Citation>Baczyk M, Alami NO, Delestree N, Martinot C, Tang L, Commisso B, et al. Synaptic restoration by cAMP/PKA drives activity&#x2010;dependent neuroprotection to motoneurons in ALS. J Exp Med. 2020;217. 10.1084/jem.20191734</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20191734</ArticleId><ArticleId IdType="pmc">PMC7398175</ArticleId><ArticleId IdType="pubmed">32484501</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Q, Martin LJ. Glycinergic innervation of motoneurons is deficient in amyotrophic lateral sclerosis mice a quantitative confocal analysis. Am J Pathol. 2009;174:574&#x2013;85. 10.2353/ajpath.2009.080557</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2009.080557</ArticleId><ArticleId IdType="pmc">PMC2630565</ArticleId><ArticleId IdType="pubmed">19116365</ArticleId></ArticleIdList></Reference><Reference><Citation>Delestr&#xe9;e N, Manuel M, Iglesias C, Elbasiouny SM, Heckman CJ, Zytnicki D. Adult spinal motoneurones are not hyperexcitable in a mouse model of inherited amyotrophic lateral sclerosis. J Physiol. 2014;592:1687&#x2013;703. 10.1113/jphysiol.2013.265843</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2013.265843</ArticleId><ArticleId IdType="pmc">PMC3979619</ArticleId><ArticleId IdType="pubmed">24445319</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez&#x2010;Silva ML, Imhoff&#x2010;Manuel RD, Sharma A, Heckman CJ, Shneider NA, Roselli F, et al. Hypoexcitability precedes denervation in the large fast&#x2010;contracting motor units in two unrelated mouse models of ALS. Elife. 2018;7. 10.7554/eLife.30955</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.30955</ArticleId><ArticleId IdType="pmc">PMC5922970</ArticleId><ArticleId IdType="pubmed">29580378</ArticleId></ArticleIdList></Reference><Reference><Citation>Roselli F, Caroni P. From intrinsic firing properties to selective neuronal vulnerability in neurodegenerative diseases. Neuron. 2015;85:901&#x2013;10. 10.1016/j.neuron.2014.12.063</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.12.063</ArticleId><ArticleId IdType="pubmed">25741719</ArticleId></ArticleIdList></Reference><Reference><Citation>Schutz B. Imbalanced excitatory to inhibitory synaptic input precedes motor neuron degeneration in an animal model of amyotrophic lateral sclerosis. Neurobiol Dis. 2005;20:131&#x2013;40. 10.1016/j.nbd.2005.02.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2005.02.006</ArticleId><ArticleId IdType="pubmed">16137574</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang DW, Lopes EC, Cheema SS. Loss of synaptophysin&#x2010;positive boutons on lumbar motor neurons innervating the medial gastrocnemius muscle of the SOD1G93A G1H transgenic mouse model of ALS. J Neurosci Res. 2005;79:694&#x2013;9. 10.1002/jnr.20379</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.20379</ArticleId><ArticleId IdType="pubmed">15668955</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao P, Ignacio S, Beattie EC, Abood ME. Altered presymptomatic AMPA and cannabinoid receptor trafficking in motor neurons of ALS model mice: implications for excitotoxicity. Eur J Neurosci. 2008;27:572&#x2013;9. 10.1111/j.1460-9568.2008.06041.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2008.06041.x</ArticleId><ArticleId IdType="pmc">PMC3991137</ArticleId><ArticleId IdType="pubmed">18279310</ArticleId></ArticleIdList></Reference><Reference><Citation>Conradi S, Kellerth JO, Berthold CH. Electron microscopic studies of serially sectioned cat spinal alpha&#x2010;motoneurons. II. A method for the description of architecture and synaptology of the cell body and proximal dendritic segments. J Comp Neurol. 1979;184:741&#x2013;54. 10.1002/cne.901840407</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.901840407</ArticleId><ArticleId IdType="pubmed">422760</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen BN. Morphological correlates of synaptic transmission in lamprey spinal cord. J Neurophysiol. 1976;39:197&#x2013;212. 10.1152/jn.1976.39.2.197</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.1976.39.2.197</ArticleId><ArticleId IdType="pubmed">176330</ArticleId></ArticleIdList></Reference><Reference><Citation>Haimann C, Torri&#x2010;Tarelli F, Fesce R, Ceccarelli B. Measurement of quantal secretion induced by ouabain and its correlation with depletion of synaptic vesicles. J Cell Biol. 1985;101:1953&#x2013;65. 10.1083/jcb.101.5.1953</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.101.5.1953</ArticleId><ArticleId IdType="pmc">PMC2113948</ArticleId><ArticleId IdType="pubmed">3932368</ArticleId></ArticleIdList></Reference><Reference><Citation>Heuser JE, Reese TS. Evidence for recycling of synaptic vesicle membrane during transmitter release at the frog neuromuscular junction. J Cell Biol. 1973;57:315&#x2013;44. 10.1083/jcb.57.2.315</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.57.2.315</ArticleId><ArticleId IdType="pmc">PMC2108984</ArticleId><ArticleId IdType="pubmed">4348786</ArticleId></ArticleIdList></Reference><Reference><Citation>Soykan T, Kaempf N, Sakaba T, Vollweiter D, Goerdeler F, Puchkov D, et al. Synaptic vesicle endocytosis occurs on multiple timescales and is mediated by formin&#x2010;dependent actin assembly. Neuron. 2017;93:854&#x2013;866.e854. 10.1016/j.neuron.2017.02.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.02.011</ArticleId><ArticleId IdType="pubmed">28231467</ArticleId></ArticleIdList></Reference><Reference><Citation>Miles GB, Hartley R, Todd AJ, Brownstone RM. Spinal cholinergic interneurons regulate the excitability of motoneurons during locomotion. Proc Natl Acad Sci USA. 2007;104:2448&#x2013;53. 10.1073/pnas.0611134104</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0611134104</ArticleId><ArticleId IdType="pmc">PMC1794344</ArticleId><ArticleId IdType="pubmed">17287343</ArticleId></ArticleIdList></Reference><Reference><Citation>Dukkipati SS, Chihi A, Wang Y, Elbasiouny SM. Experimental design and data analysis issues contribute to inconsistent results of C&#x2010;bouton changes in amyotrophic lateral sclerosis. eNeuro. 2017;4:ENEURO.0281&#x2010;16.2016. 10.1523/ENEURO.0281-16.2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/ENEURO.0281-16.2016</ArticleId><ArticleId IdType="pmc">PMC5241941</ArticleId><ArticleId IdType="pubmed">28101533</ArticleId></ArticleIdList></Reference><Reference><Citation>Casas C, Herrando&#x2010;Grabulosa M, Manzano R, Mancuso R, Osta R, Navarro X. Early presymptomatic cholinergic dysfunction in a murine model of amyotrophic lateral sclerosis. Brain Behav. 2013;3:145&#x2013;58. 10.1002/brb3.104</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.104</ArticleId><ArticleId IdType="pmc">PMC3607155</ArticleId><ArticleId IdType="pubmed">23531559</ArticleId></ArticleIdList></Reference><Reference><Citation>Herron LR, Miles GB. Gender&#x2010;specific perturbations in modulatory inputs to motoneurons in a mouse model of amyotrophic lateral sclerosis. Neuroscience. 2012;226:313&#x2013;23. 10.1016/j.neuroscience.2012.09.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2012.09.031</ArticleId><ArticleId IdType="pubmed">23000617</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasiene J, Komine O, Fujimori&#x2010;Tonou N, Powers B, Endo F, Watanabe S, et al. Neuregulin 1 confers neuroprotection in SOD1&#x2010;linked amyotrophic lateral sclerosis mice via restoration of C&#x2010;boutons of spinal motor neurons. Acta Neuropathol Commun. 2016;4:15. 10.1186/s40478-016-0286-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0286-7</ArticleId><ArticleId IdType="pmc">PMC4758105</ArticleId><ArticleId IdType="pubmed">26891847</ArticleId></ArticleIdList></Reference><Reference><Citation>Milan L, Courtand G, Cardoit L, Masmejean F, Barriere G, Cazalets JR, et al. Age&#x2010;related changes in pre&#x2010; and postsynaptic partners of the cholinergic C&#x2010;boutons in wild&#x2010;type and SOD1G93A lumbar motoneurons. PLoS One. 2015;10:e0135525. 10.1371/journal.pone.0135525</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0135525</ArticleId><ArticleId IdType="pmc">PMC4549056</ArticleId><ArticleId IdType="pubmed">26305672</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagao M, Misawa H, Kato S, Hirai S. Loss of cholinergic synapses on the spinal motor neurons of amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 1998;57:329&#x2013;33. 10.1097/00005072-199804000-00004</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-199804000-00004</ArticleId><ArticleId IdType="pubmed">9600225</ArticleId></ArticleIdList></Reference><Reference><Citation>Pullen AH, Athanasiou D. Increase in presynaptic territory of C&#x2010;terminals on lumbar motoneurons of G93A SOD1 mice during disease progression. Eur J Neurosci. 2009;29:551&#x2013;61. 10.1111/j.1460-9568.2008.06602.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2008.06602.x</ArticleId><ArticleId IdType="pubmed">19187267</ArticleId></ArticleIdList></Reference><Reference><Citation>Casanovas A, Salvany S, Lahoz V, Tarabal O, Piedrafita L, Sabater R, et al. Neuregulin 1&#x2010;ErbB module in C&#x2010;bouton synapses on somatic motor neurons: molecular compartmentation and response to peripheral nerve injury. Sci Rep. 2017;7:40155. 10.1038/srep40155</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep40155</ArticleId><ArticleId IdType="pmc">PMC5220293</ArticleId><ArticleId IdType="pubmed">28065942</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallart&#x2010;Palau X, Tarabal O, Casanovas A, Sabado J, Correa FJ, Hereu M, et al. Neuregulin&#x2010;1 is concentrated in the postsynaptic subsurface cistern of C&#x2010;bouton inputs to alpha&#x2010;motoneurons and altered during motoneuron diseases. FASEB J. 2014;28:3618&#x2013;32. 10.1096/fj.13-248583</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.13-248583</ArticleId><ArticleId IdType="pubmed">24803543</ArticleId></ArticleIdList></Reference><Reference><Citation>Deardorff AS, Romer SH, Fyffe REW. Location, location, location: the organization and roles of potassium channels in mammalian motoneurons. J Physiol. 2021;599:1391&#x2013;420. 10.1113/JP278675</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP278675</ArticleId><ArticleId IdType="pubmed">33449375</ArticleId></ArticleIdList></Reference><Reference><Citation>Witts EC, Zagoraiou L, Miles GB. Anatomy and function of cholinergic C bouton inputs to motor neurons. J Anat. 2014;224:52&#x2013;60. 10.1111/joa.12063</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joa.12063</ArticleId><ArticleId IdType="pmc">PMC3867887</ArticleId><ArticleId IdType="pubmed">23701140</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, Zhao W, Liao B, Kano O, Wang J, Huang A, et al. Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice. Brain Behav Immun. 2011;25:1025&#x2013;35. 10.1016/j.bbi.2010.12.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2010.12.008</ArticleId><ArticleId IdType="pmc">PMC3096756</ArticleId><ArticleId IdType="pubmed">21176785</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke BE, Patani R. The microglial component of amyotrophic lateral sclerosis. Brain. 2020;143:3526&#x2013;39. 10.1093/brain/awaa309</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa309</ArticleId><ArticleId IdType="pmc">PMC7805793</ArticleId><ArticleId IdType="pubmed">33427296</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Erchia AM, Gallo A, Manzari C, Raho S, Horner DS, Chiara M, et al. Massive transcriptome sequencing of human spinal cord tissues provides new insights into motor neuron degeneration in ALS. Sci Rep. 2017;7. 10.1038/S41598-017-10488-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41598-017-10488-7</ArticleId><ArticleId IdType="pmc">PMC5577269</ArticleId><ArticleId IdType="pubmed">28855684</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakes AE, Ferraiuolo L, Haidet&#x2010;Phillips AM, Schmelzer L, Braun L, Miranda CJ, et al. Microglia induce motor neuron death via the classical NF&#x2010;kappaB pathway in amyotrophic lateral sclerosis. Neuron. 2014;81:1009&#x2013;23. 10.1016/j.neuron.2014.01.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.013</ArticleId><ArticleId IdType="pmc">PMC3978641</ArticleId><ArticleId IdType="pubmed">24607225</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, Wichterle H, et al. Astrocytes expressing ALS&#x2010;linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci. 2007;10:615&#x2013;22. 10.1038/nn1876</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1876</ArticleId><ArticleId IdType="pmc">PMC3799799</ArticleId><ArticleId IdType="pubmed">17435755</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T, Robberecht W. Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol. 2011;10:253&#x2013;63. 10.1016/S1474-4422(11)70015-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(11)70015-1</ArticleId><ArticleId IdType="pubmed">21349440</ArticleId></ArticleIdList></Reference><Reference><Citation>Geloso MC, Corvino V, Marchese E, Serrano A, Michetti F, D'Ambrosi N. The dual role of microglia in ALS: mechanisms and therapeutic approaches. Front Aging Neurosci. 2017;9:242. 10.3389/fnagi.2017.00242</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00242</ArticleId><ArticleId IdType="pmc">PMC5524666</ArticleId><ArticleId IdType="pubmed">28790913</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, Beers DR, Appel SH. Immune&#x2010;mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis. J Neuroimmune Pharmacol. 2013;8:888&#x2013;99. 10.1007/s11481-013-9489-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-013-9489-x</ArticleId><ArticleId IdType="pmc">PMC4126425</ArticleId><ArticleId IdType="pubmed">23881705</ArticleId></ArticleIdList></Reference><Reference><Citation>Maniatis S, Aijo T, Vickovic S, Braine C, Kang K, Mollbrink A, et al. Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis. Science. 2019;364:89&#x2013;93. 10.1126/science.aav9776</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav9776</ArticleId><ArticleId IdType="pubmed">30948552</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanagi T, Yuasa S, Nakamura Y, Suzuki E, Aoki M, Warita H, et al. Appearance of phagocytic microglia adjacent to motoneurons in spinal cord tissue from a presymptomatic transgenic rat model of amyotrophic lateral sclerosis. J Neurosci Res. 2010;88:2736&#x2013;46. 10.1002/jnr.22424</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.22424</ArticleId><ArticleId IdType="pubmed">20648658</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichert F, Rotshenker S. Galectin&#x2010;3 (MAC&#x2010;2) controls microglia phenotype whether amoeboid and phagocytic or branched and non&#x2010;phagocytic by regulating the cytoskeleton. Front Cell Neurosci. 2019;13:90. 10.3389/fncel.2019.00090</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00090</ArticleId><ArticleId IdType="pmc">PMC6427835</ArticleId><ArticleId IdType="pubmed">30930748</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki Y, Hoshi M, Akazawa C, Nakamura Y, Tsuzuki H, Inoue K, et al. Selective expression of Gi/o&#x2010;coupled ATP receptor P2Y12 in microglia in rat brain. Glia. 2003;44:242&#x2013;50. 10.1002/glia.10293</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.10293</ArticleId><ArticleId IdType="pubmed">14603465</ArticleId></ArticleIdList></Reference><Reference><Citation>Haynes SE, Hollopeter G, Yang G, Kurpius D, Dailey ME, Gan WB, et al. The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat Neurosci. 2006;9:1512&#x2013;9. 10.1038/nn1805</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1805</ArticleId><ArticleId IdType="pubmed">17115040</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadon&#x2010;Nachum M, Melamed E, Offen D. The "dying&#x2010;back" phenomenon of motor neurons in ALS. J Mol Neurosci. 2011;43:470&#x2013;7. 10.1007/s12031-010-9467-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-010-9467-1</ArticleId><ArticleId IdType="pubmed">21057983</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariotti R, Cristino L, Bressan C, Boscolo S, Bentivoglio M. Altered reaction of facial motoneurons to axonal damage in the presymptomatic phase of a murine model of familial amyotrophic lateral sclerosis. Neuroscience. 2002;115:331&#x2013;5. 10.1016/s0306-4522(02)00448-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0306-4522(02)00448-7</ArticleId><ArticleId IdType="pubmed">12421599</ArticleId></ArticleIdList></Reference><Reference><Citation>Schram S, Chuang D, Schmidt G, Piponov H, Helder C, Kerns J, et al. Mutant SOD1 prevents normal functional recovery through enhanced glial activation and loss of motor neuron innervation after peripheral nerve injury. Neurobiol Dis. 2019;124:469&#x2013;78. 10.1016/j.nbd.2018.12.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.12.020</ArticleId><ArticleId IdType="pubmed">30594811</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharp PS, Dick JR, Greensmith L. The effect of peripheral nerve injury on disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Neuroscience. 2005;130:897&#x2013;910. 10.1016/j.neuroscience.2004.09.069</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2004.09.069</ArticleId><ArticleId IdType="pubmed">15652988</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong J, Xu Z. Peripheral axotomy slows motoneuron degeneration in a transgenic mouse line expressing mutant SOD1 G93A. J Comp Neurol. 1999;412:373&#x2013;80. 10.1002/(sici)1096-9861(19990920)412:2&lt;373::aid-cne13&gt;3.0.co;2-n</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(sici)1096-9861(19990920)412:2&lt;373::aid-cne13&gt;3.0.co;2-n</ArticleId><ArticleId IdType="pubmed">10441762</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharp PS, Tyreman N, Jones KE, Gordon T. Crush injury to motor nerves in the G93A transgenic mouse model of amyotrophic lateral sclerosis promotes muscle reinnervation and survival of functionally intact nerve&#x2010;muscle contacts. Neurobiol Dis. 2018;113:33&#x2013;44. 10.1016/j.nbd.2018.01.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.01.019</ArticleId><ArticleId IdType="pubmed">29409912</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvany S, Casanovas A, Tarabal O, Piedrafita L, Hernandez S, Santafe M, et al. Localization and dynamic changes of neuregulin&#x2010;1 at C&#x2010;type synaptic boutons in association with motor neuron injury and repair. FASEB J. 2019;33:7833&#x2013;51. 10.1096/fj.201802329R</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201802329R</ArticleId><ArticleId IdType="pubmed">30912977</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, Henkel JS, Xiao Q, Zhao W, Wang J, Yen AA, et al. Wild&#x2010;type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA. 2006;103:16021&#x2013;6. 10.1073/pnas.0607423103</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0607423103</ArticleId><ArticleId IdType="pmc">PMC1613228</ArticleId><ArticleId IdType="pubmed">17043238</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, Beers DR, Henkel JS, Zhang W, Urushitani M, Julien JP, et al. Extracellular mutant SOD1 induces microglial&#x2010;mediated motoneuron injury. Glia. 2010;58:231&#x2013;43. 10.1002/glia.20919</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.20919</ArticleId><ArticleId IdType="pmc">PMC2784168</ArticleId><ArticleId IdType="pubmed">19672969</ArticleId></ArticleIdList></Reference><Reference><Citation>Gros&#x2010;Louis F, Soucy G, Lariviere R, Julien JP. Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS. J Neurochem. 2010;113:1188&#x2013;99. 10.1111/j.1471-4159.2010.06683.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2010.06683.x</ArticleId><ArticleId IdType="pubmed">20345765</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu HN, Tjostheim S, Dasilva K, Taylor D, Zhao B, Rakhit R, et al. Targeting of monomer/misfolded SOD1 as a therapeutic strategy for amyotrophic lateral sclerosis. J Neurosci. 2012;32:8791&#x2013;9. 10.1523/JNEUROSCI.5053-11.2012</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5053-11.2012</ArticleId><ArticleId IdType="pmc">PMC6622344</ArticleId><ArticleId IdType="pubmed">22745481</ArticleId></ArticleIdList></Reference><Reference><Citation>Raoul C, Abbas&#x2010;Terki T, Bensadoun JC, Guillot S, Haase G, Szulc J, et al. Lentiviral&#x2010;mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS. Nat Med. 2005;11:423&#x2013;8. 10.1038/nm1207</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1207</ArticleId><ArticleId IdType="pubmed">15768028</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabado J, Casanovas A, Rodrigo H, Arque G, Esquerda JE. Adverse effects of a SOD1&#x2010;peptide immunotherapy on SOD1 G93A mouse slow model of amyotrophic lateral sclerosis. Neuroscience. 2015;310:38&#x2013;50. 10.1016/j.neuroscience.2015.09.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.09.027</ArticleId><ArticleId IdType="pubmed">26384962</ArticleId></ArticleIdList></Reference><Reference><Citation>Dal Canto MC, Gurney ME. Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am J Pathol. 1994;145:1271&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1887498</ArticleId><ArticleId IdType="pubmed">7992831</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder&#xf3; J, Ciutat D, Llad&#xf3; J, Cast&#xe1;n E, Oppenheim RW, Esquerda JE. Effects of excitatory amino acids on neuromuscular development in the chick embryo. J Comp Neurol. 1997;387:73&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">9331173</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishimaru MJ, Ikonomidou C, Tenkova TI, Der TC, Dikranian K, Sesma MA, et al. Distinguishing excitotoxic from apoptotic neurodegeneration in the developing rat brain. J Comp Neurol. 1999;408:461&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">10340498</ArticleId></ArticleIdList></Reference><Reference><Citation>Javadov S, Chapa&#x2010;Dubocq X, Makarov V. Different approaches to modeling analysis of mitochondrial swelling. Mitochondrion. 2018;38:58&#x2013;70. 10.1016/j.mito.2017.08.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2017.08.004</ArticleId><ArticleId IdType="pmc">PMC5752577</ArticleId><ArticleId IdType="pubmed">28802667</ArticleId></ArticleIdList></Reference><Reference><Citation>Israelson A, Arbel N, Da Cruz S, Ilieva H, Yamanaka K, Shoshan&#x2010;Barmatz V, et al. Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS. Neuron. 2010;67:575&#x2013;87. 10.1016/j.neuron.2010.07.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.07.019</ArticleId><ArticleId IdType="pmc">PMC2941987</ArticleId><ArticleId IdType="pubmed">20797535</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedrini S, Sau D, Guareschi S, Bogush M, Brown RH Jr, Naniche N, et al. ALS&#x2010;linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl&#x2010;2. Hum Mol Genet. 2010;19:2974&#x2013;86. 10.1093/hmg/ddq202</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq202</ArticleId><ArticleId IdType="pmc">PMC2901139</ArticleId><ArticleId IdType="pubmed">20460269</ArticleId></ArticleIdList></Reference><Reference><Citation>Vander Jagt TA, Connor JA, Shuttleworth CW. Localized loss of Ca2+ homeostasis in neuronal dendrites is a downstream consequence of metabolic compromise during extended NMDA exposures. J Neurosci. 2008;28:5029&#x2013;39. 10.1523/JNEUROSCI.5069-07.2008</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5069-07.2008</ArticleId><ArticleId IdType="pmc">PMC2707144</ArticleId><ArticleId IdType="pubmed">18463256</ArticleId></ArticleIdList></Reference><Reference><Citation>Filipchuk A, Pambo&#x2010;Pambo A, Gaudel F, Liabeuf S, Brocard C, Gueritaud JP, et al. Early hypoexcitability in a subgroup of spinal motoneurons in superoxide dismutase 1 transgenic mice, a model of amyotrophic lateral sclerosis. Neuroscience. 2021;463:337&#x2013;53. 10.1016/j.neuroscience.2021.01.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2021.01.039</ArticleId><ArticleId IdType="pubmed">33556455</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruegsegger C, Maharjan N, Goswami A, Filezac de L'Etang A, Weis J, Troost D, et al. Aberrant association of misfolded SOD1 with Na(+)/K(+)ATPase&#x2010;alpha3 impairs its activity and contributes to motor neuron vulnerability in ALS. Acta Neuropathol. 2016;131:427&#x2013;51. 10.1007/s00401-015-1510-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1510-4</ArticleId><ArticleId IdType="pubmed">26619836</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemler ME. Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol. 2005;6:801&#x2013;11. 10.1038/nrm1736</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm1736</ArticleId><ArticleId IdType="pubmed">16314869</ArticleId></ArticleIdList></Reference><Reference><Citation>Picca A, Beli R, Calvani R, Coelho&#x2010;Junior HJ, Landi F, Bernabei R, et al. Older adults with physical frailty and sarcopenia show increased levels of circulating small extracellular vesicles with a specific mitochondrial signature. Cell. 2020;9. 10.3390/cells9040973</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9040973</ArticleId><ArticleId IdType="pmc">PMC7227017</ArticleId><ArticleId IdType="pubmed">32326435</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellingham SA, Guo BB, Coleman BM, Hill AF. Exosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases? Front Physiol. 2012;3:124. 10.3389/fphys.2012.00124</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2012.00124</ArticleId><ArticleId IdType="pmc">PMC3342525</ArticleId><ArticleId IdType="pubmed">22563321</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad LI, Yerbury JJ, Turner BJ, Guest WC, Pokrishevsky E, O'Neill MA, et al. Intercellular propagated misfolding of wild&#x2010;type Cu/Zn superoxide dismutase occurs via exosome&#x2010;dependent and &#x2010;independent mechanisms. Proc Natl Acad Sci USA. 2014;111:3620&#x2013;5. 10.1073/pnas.1312245111</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1312245111</ArticleId><ArticleId IdType="pmc">PMC3948312</ArticleId><ArticleId IdType="pubmed">24550511</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman JM, Christy D, Shyu CC, Moon KM, Fernando S, Gidden Z, et al. CNS&#x2010;derived extracellular vesicles from superoxide dismutase 1 (SOD1)(G93A) ALS mice originate from astrocytes and neurons and carry misfolded SOD1. J Biol Chem. 2019;294:3744&#x2013;59. 10.1074/jbc.RA118.004825</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.004825</ArticleId><ArticleId IdType="pmc">PMC6416428</ArticleId><ArticleId IdType="pubmed">30635404</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi AU, Saw NL, Vogel H, Cunnigham AD, Shamloo M, Mochly&#x2010;Rosen D. Inhibition of Drp1/Fis1 interaction slows progression of amyotrophic lateral sclerosis. EMBO Mol Med. 2018;10. 10.15252/emmm.201708166</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201708166</ArticleId><ArticleId IdType="pmc">PMC5840540</ArticleId><ArticleId IdType="pubmed">29335339</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayakawa K, Esposito E, Wang X, Terasaki Y, Liu Y, Xing C, et al. Transfer of mitochondria from astrocytes to neurons after stroke. Nature. 2016;535:551&#x2013;5. 10.1038/nature18928</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature18928</ArticleId><ArticleId IdType="pmc">PMC4968589</ArticleId><ArticleId IdType="pubmed">27466127</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi AU, Minhas PS, Liddelow SA, Haileselassie B, Andreasson KI, Dorn GW II, et al. Fragmented mitochondria released from microglia trigger A1 astrocytic response and propagate inflammatory neurodegeneration. Nat Neurosci. 2019;22:1635&#x2013;48. 10.1038/s41593-019-0486-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0486-0</ArticleId><ArticleId IdType="pmc">PMC6764589</ArticleId><ArticleId IdType="pubmed">31551592</ArticleId></ArticleIdList></Reference><Reference><Citation>Re DB, Le Verche V, Yu C, Amoroso MW, Politi KA, Phani S, et al. Necroptosis drives motor neuron death in models of both sporadic and familial ALS. Neuron. 2014;81:1001&#x2013;8. 10.1016/j.neuron.2014.01.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.011</ArticleId><ArticleId IdType="pmc">PMC3951532</ArticleId><ArticleId IdType="pubmed">24508385</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito Y, Ofengeim D, Najafov A, Das S, Saberi S, Li Y, et al. RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS. Science. 2016;353:603&#x2013;8. 10.1126/science.aaf6803</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf6803</ArticleId><ArticleId IdType="pmc">PMC5444917</ArticleId><ArticleId IdType="pubmed">27493188</ArticleId></ArticleIdList></Reference><Reference><Citation>Dermentzaki G, Politi KA, Lu L, Mishra V, P&#xe9;rez&#x2010;Torres EJ, Sosunov AA, et al. Deletion of Ripk3 prevents motor neuron death in vitro but not in vivo. eNeuro. 2019;6:ENEURO.0308&#x2010;18.2018. 10.1523/ENEURO.0308-18.2018</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/ENEURO.0308-18.2018</ArticleId><ArticleId IdType="pmc">PMC6391588</ArticleId><ArticleId IdType="pubmed">30815534</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez S, Varfolomeev E, Brendza R, Stark K, Tea J, Imperio J, et al. Genetic inactivation of RIP1 kinase does not ameliorate disease in a mouse model of ALS. Cell Death Differ. 2021;28:915&#x2013;31. 10.1038/s41418-020-00625-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-020-00625-7</ArticleId><ArticleId IdType="pmc">PMC7937687</ArticleId><ArticleId IdType="pubmed">32994544</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, Perera ND, Chiam MDF, Cuic B, Wanniarachchillage N, Tomas D, et al. Necroptosis is dispensable for motor neuron degeneration in a mouse model of ALS. Cell Death Differ. 2020;27:1728&#x2013;39. 10.1038/s41418-019-0457-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-019-0457-8</ArticleId><ArticleId IdType="pmc">PMC7206015</ArticleId><ArticleId IdType="pubmed">31745214</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Q, Zhao W, Beers DR, Yen AA, Xie W, Henkel JS, et al. Mutant SOD1(G93A) microglia are more neurotoxic relative to wild&#x2010;type microglia. J Neurochem. 2007;102:2008&#x2013;19. 10.1111/j.1471-4159.2007.04677.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2007.04677.x</ArticleId><ArticleId IdType="pubmed">17555556</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>